Enviva Takes Huge Stock Price Hit

Enviva’s stock price, which has been falling all year from a high of $51 in January, sank to under a $1 a share after a new interim CEO delivered a sobering third-quarter earnings call that raised questions about the company’s viability, blaming unfavorable wood pellet pricing, problems at a plant in Virginia, higher interest expenses and other factors.

In its third quarter Security and Exchange Commission filing, Enviva cautioned that “these conditions and events in the aggregate raise substantial doubt regarding the company’s ability to continue as a going concern.”

As investors rushed for the exits, Bloomberg reported a one-day stock price drop of 79 percent. Interim CEO Glenn Nunziata (Enviva’s chief financial officer taking on the interim role) said the organization is urgently moving to “execute a multifaceted transformation plan.” He added that executives would be reviewing the company’s contracts and debt.

Latest news

Chris Brown Assumes Role As Mid-South President

Chris Brown Assumes Role As Mid-South President  Mid-South Engineering recently bid a happy retirement to President Marc Stewart after 27 years with the company. "Leaving my daily interactions with this team leaves a Mid-South-logo-shaped hole in my heart," Stewart...

read more

Con-Vey Expands Operations In Oregon

Con-Vey Expands Operations In OregonCon-Vey is planning an expansion of its operations with the acquisition of approximately 15 additional acres, including 150,000 sq. ft. of manufacturing space. Strategically located with both highway and freeway access, and just 6.3...

read more

Find Us On Social

Subscribe to Our Newsletter

Wood Bioenergy News Online hits the inboxes of subscribers in the wood-to-energy sectors.

Subscribe/Renew

Wood Bioenergy is published and delivered worldwide 6 times per year. Free to qualified readers in the U.S. Subscribers outside the U.S. are asked to pay a small fee.

Advertise

Complete the online form so we can direct you to the appropriate Sales Representative.